JP2024533291A5 - - Google Patents
Info
- Publication number
- JP2024533291A5 JP2024533291A5 JP2024515026A JP2024515026A JP2024533291A5 JP 2024533291 A5 JP2024533291 A5 JP 2024533291A5 JP 2024515026 A JP2024515026 A JP 2024515026A JP 2024515026 A JP2024515026 A JP 2024515026A JP 2024533291 A5 JP2024533291 A5 JP 2024533291A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163241891P | 2021-09-08 | 2021-09-08 | |
| US63/241,891 | 2021-09-08 | ||
| PCT/EP2022/058574 WO2023036473A1 (en) | 2021-09-08 | 2022-03-31 | Combination drug therapies |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024533291A JP2024533291A (ja) | 2024-09-12 |
| JPWO2023036473A5 JPWO2023036473A5 (https=) | 2025-03-25 |
| JP2024533291A5 true JP2024533291A5 (https=) | 2025-03-25 |
Family
ID=81325378
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024515026A Pending JP2024533291A (ja) | 2021-09-08 | 2022-03-31 | 併用薬物療法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240366655A1 (https=) |
| EP (1) | EP4398871A1 (https=) |
| JP (1) | JP2024533291A (https=) |
| KR (1) | KR20240052775A (https=) |
| AU (1) | AU2022342266B2 (https=) |
| CA (1) | CA3231021A1 (https=) |
| WO (1) | WO2023036473A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021268204A1 (en) | 2020-05-08 | 2022-12-08 | Psilera Inc. | Novel compositions of matter and pharmaceutical compositions |
| KR20240096817A (ko) | 2020-05-19 | 2024-06-26 | 사이빈 아이알엘 리미티드 | 중수소화된 트립타민 유도체 및 사용 방법 |
| US12122741B2 (en) | 2020-08-18 | 2024-10-22 | Cybin Irl Limited | Therapeutic phenethylamine compositions and methods of use |
| IL308816A (en) | 2021-05-25 | 2024-01-01 | Atai Therapeutics Inc | New n,n-dimethyltryptamine salts and crystalline salt forms |
| MX2023014620A (es) | 2021-06-09 | 2024-01-30 | Atai Therapeutics Inc | Nuevos profarmacos y conjugados de dimetiltriptamina. |
| JP2024545787A (ja) | 2021-12-30 | 2024-12-11 | アタイ セラピューティクス， インコーポレイテッド | 一酸化窒素送達剤としてのジメチルトリプタミン類似体 |
| GB202214721D0 (en) * | 2022-10-06 | 2022-11-23 | Rewire Therapeutics Ltd | A treatment for mental disorders |
| EP4704826A1 (en) * | 2023-04-28 | 2026-03-11 | Yale University | Compositions and methods for treating post-traumatic stress disorder |
| US12303503B1 (en) | 2023-11-16 | 2025-05-20 | Biobina Llc | Use of dextromethorphan in combination with CYP2D6 and CYP3A4 enzyme inhibitors for the treatment of pain |
| WO2025123137A1 (en) * | 2023-12-15 | 2025-06-19 | 10763942 Canada Inc. (Dba. Purminds Neuropharma) | Heterocyclic compounds and methods of preparation thereof |
| WO2025170990A1 (en) * | 2024-02-06 | 2025-08-14 | Atai Therapeutics, Inc. | Controlled transmucosal release of dmt in combination with a monoamine oxidase inhibitor |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5612059A (en) | 1988-08-30 | 1997-03-18 | Pfizer Inc. | Use of asymmetric membranes in delivery devices |
| US5798119A (en) | 1995-06-13 | 1998-08-25 | S. C. Johnson & Son, Inc. | Osmotic-delivery devices having vapor-permeable coatings |
| US7267121B2 (en) | 2004-04-20 | 2007-09-11 | Aerogen, Inc. | Aerosol delivery apparatus and method for pressure-assisted breathing systems |
| EP4219498A1 (en) * | 2019-03-07 | 2023-08-02 | Arbormentis LLC | Compositions and methods of use comprising substances with neural plasticity actions administered at non-psychedelic / psychotomimetic dosages and formulations |
| KR20220009954A (ko) * | 2019-04-17 | 2022-01-25 | 컴퍼스 패쓰파인더 리미티드 | 신경인지 장애, 만성 통증을 치료하고 염증을 감소시키는 방법 |
| WO2021003467A1 (en) * | 2019-07-04 | 2021-01-07 | Sw Holdings, Inc. | Metered dosing compositions and methods of use of psychedelic compounds |
| RU199823U1 (ru) | 2020-06-10 | 2020-09-21 | Общество С Ограниченной Ответственностью "Центр Передовых Радиационных Медицинских И Биологических Технологий | Устройство для лечения бронхолегочных заболеваний |
-
2022
- 2022-03-31 WO PCT/EP2022/058574 patent/WO2023036473A1/en not_active Ceased
- 2022-03-31 AU AU2022342266A patent/AU2022342266B2/en active Active
- 2022-03-31 CA CA3231021A patent/CA3231021A1/en active Pending
- 2022-03-31 US US18/688,125 patent/US20240366655A1/en active Pending
- 2022-03-31 KR KR1020247008355A patent/KR20240052775A/ko active Pending
- 2022-03-31 JP JP2024515026A patent/JP2024533291A/ja active Pending
- 2022-03-31 EP EP22716971.1A patent/EP4398871A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024533291A5 (https=) | ||
| BR102022025291A2 (https=) | ||
| CL2026000520A1 (es) | Una estructura de jaula flotante para peces con faldón contra piojos | |
| CL2025004093A1 (es) | Anticuerpos de unión a proteína de activación de fibroblastos alfa y receptor de muerte 4 | |
| CL2025003924A1 (es) | Sistemas y métodos para explosión comercial. | |
| BR102023001877A2 (https=) | ||
| BR102023000289A2 (https=) | ||
| BR102022026909A2 (https=) | ||
| BR102022023461A2 (https=) | ||
| BR202022009269U2 (https=) | ||
| BY23966C1 (https=) | ||
| BY13174U (https=) | ||
| CN307046951S (https=) | ||
| CN307045940S (https=) | ||
| CN307047603S (https=) | ||
| CN307045578S (https=) | ||
| CN307045529S (https=) | ||
| CN307045268S (https=) | ||
| CN307044463S (https=) | ||
| CN307044419S (https=) | ||
| CN307044358S (https=) | ||
| CN307047845S (https=) | ||
| CN307048102S (https=) | ||
| CN307048516S (https=) | ||
| BY13163U (https=) |